Advancing the management of maternal, fetal, and neonatal infection through harnessing digital health innovations

Using digital health technologies to optimise antimicrobial use globally

Serious adverse events reported with benzimidazole derivatives: A disproportionality analysis from the World Health Organization’s pharmacovigilance database

Drug risks associated with sarcopenia: a real-world and GWAS study

Isotretinoin and Suicide: Data Mining of the United States Food and Drug Administration Adverse Event Reporting System Database

Using multiple drug similarity networks to promote adverse drug event detection

Reporting of late-onset immune-related adverse events with immune checkpoint inhibitors in VigiBase

Descriptive analysis of adverse events following immunization with oral cholera vaccine in Lebanon

Drug-related problems among pediatric intensive care units: prevalence, risk factors, and clinical pharmacists’ interventions

Reusability report: exploring the utility of variational graph encoders for predicting molecular toxicity in drug design

Anti-Cancer Drug-Induced Lyell’s Syndrome: A Series of Two Patients

The evolution of the Pharmacovigilance department in the pharmaceutical industry: results of an Italian national survey

Evaluating Sex-Biased Adverse Event-Associated Drugs to Improve Kidney Disease Drug Prioritization TH-PO116

Leukocytes telomere length as a biomarker of adverse drug reactions induced by Osimertinib in advanced non-small cell lung cancer

Cancer and treatment specific incidence rates of immune-related adverse events induced by immune checkpoint inhibitors: a systematic review

Temporal trends in online searches related to COVID-19 vaccine safety: A digital infodemiology study

Clonazepam Recall Grows Over Potentially Life-Threatening Label Error

Eliminate Clozapine REMS, FDA Panels Say

Implementation Status and Challenges of Pharmacovigilance Program in Ethiopia: A Mixed-Methods Study

Deprescribing oral antidiabetics in elderly patients: Do electronic leaflets across the world address it?

Advances in drug-induced liver injury research: in vitro models, mechanisms, omics and gene modulation techniques

Views on the Development and Use of a New Digital Adverse Drug Event Reporting Platform in Australia: A Qualitative Study

Integrating electronic health records with other data sources for postmarket drug safety signal identification: a review

Association between different GLP-1 receptor agonists and acute pancreatitis: case series and real-world pharmacovigilance analysis

Implementation Status and Challenges of Pharmacovigilance Program in Ethiopia: A Mixed-Methods Study

Integrating electronic health records with other data sources for postmarket drug safety signal identification: a review

Emerging Technologies in the Pharmaceutical Supply Chains: A Systematic Review of Industry 5.0 Challenges

Boletín sobre Seguridad de Medicamentos de Uso Humano. Octubre de 2024

Exclusive-US FDA Finds Widely Used Asthma Drug Impacts the Brain

Governance of artificial intelligence and machine learning in pharmacovigilance: what works today and what more is needed?

Side Effects of GLP-1 Drugs: What Doctors Should Know

Integrating Big Data, Artificial Intelligence, and motion analysis for emerging precision medicine applications in Parkinson’s Disease

Risk-stratified treatment for drug-susceptible pulmonary tuberculosis

How to Stop Bone Loss After Denosumab? No Easy Answers

The Influence of Internet-Derived Misinformation on Medical Treatment Decisions: A Social Learning Perspective

Patient-centric decision-making in supplements intake and disclosure in clinical practice: a novel SIDP-12 tool to prevent drug–supplement interaction

Retrospective analysis of survival and safety of bevacizumab biosimilar and original drug combination chemotherapy in non-small cell lung cancer

The Impact of COVID-19 on RNA Therapeutics: A Surge in Lipid Nanoparticles and Alternative Delivery Systems

Web application for assisting non-dermatology physicians in learning and managing patients with common cutaneous adverse drug reactions: a multicenter randomized controlled trial

A Review on In Details of the Pharmacovigilance

Risks of malignancies related to disease-modifying antirheumatic drugs in rheumatoid arthritis: a pharmacovigilance analysis using the FAERS database

Safety Profile of Statins for Post-Marketing Adverse Cardiovascular Events: A Real-World Pharmacovigilance Analysis

Mendelian randomization and pharmacovigilance analyses reveal the causal relationship between antidiabetic drugs and psychiatric disorders

Polygenic risk score for drug-induced long QT syndrome: independent validation in a real-world patient cohort

Efficacy and safety of traditional Chinese medicine for the treatment of epilepsy by wind quenching and phlegm resolving: A systematic review and meta-analysis

The Post-Acute Covid-Vaccination Syndrome in the light of Pharmacovigilance

A modified Delphi exercise in physician-perceived risk factors for drug-induced pneumotoxicity in patients with rheumatological disease

Differences in Drug Shortages in the US and Canada

Ensuring Virtual Vigilance in Decentralized Clinical Trials

A real-world pharmacovigilance analysis of adverse events associated with irbesartan using the FAERS and JADER databases

Untapped Potential? Representativeness in Pragmatic Clinical Trials

Inappropriate antibiotic prescription for acute tonsillitis in low- and middle-income countries (LMICs): a systematic review and meta-analysis protocol

Evaluation of tolvaptan-associated hepatic disorder using different national pharmacovigilance databases

Informing the risk assessment related to lactation and drug exposure: A physiologically based pharmacokinetic lactation model for pregabalin

Drug-associated glaucoma: A real-world study based on the Food and Drug Administration adverse event reporting system database

A real-world pharmacovigilance study of FDA adverse event reporting system events for Lutetium-177-PSMA-617

Machine learning driven bioequivalence risk assessment at an early stage of generic drug development

Safety concerns of paternal drug exposure on fertility, pregnancy and offspring: An analysis based on the FDA adverse event reporting system

Ginkgo biloba extract safety: Insights from a real-world pharmacovigilance study of FDA adverse event reporting system (FAERS) events

Knowledge, Attitude, and Practice Regarding Pharmacovigilance and Barriers to Reporting Adverse Drug Reactions Among the General Population in Saudi Arabia

Lichenoid Drug Eruption Secondary to Systemic Antibiotics: Case Report

Pharmacovigilance of Drug–Drug Interactions with Nirmatrelvir/Ritonavir

Pharmacovigilance monitoring and treatment adherence in patients on antihypertensive drugs at a tertiary care centre

Proactive therapeutic drug monitoring of biologic drugs in patients with inflammatory bowel disease, inflammatory arthritis, and psoriasis: systematic review and meta-analysis

Uma breve revisão sobre Farmacovigilância: histórico, conceitos, aplicações e resoluções norteadoras

Adverse Drug Reactions to β-Lactam Antibiotics: A Portuguese Pharmacovigilance Database Analysis

Exploring drug-induced toxic epidermal necrolysis: A case series and comprehensive review

Posición de la Academia Nacional de Medicina respecto a la disposición de la ANMAT que cataloga a los inhibidores de la bomba de protones (IBP) como de “venta libre”

Developing a Screening Strategy to Identify Hepatotoxicity and Drug Interaction Potential of Botanicals

Exploring the influencing factors of adverse drug reaction reporting among medical personnel: a COM-B model-based study

Exploring Human Misuse and Abuse of Veterinary Drugs: A Descriptive Pharmacovigilance Analysis Utilising the Food and Drug Administration’s Adverse Events Reporting System (FAERS)

The Food and Drug Administration's Safety Surveillance of Adverse Event Cases Involving Cannabinoid Hemp Products, 2019–2023

Influence of inpatient withdrawal treatment on drug safety in alcohol use disorder — a quasi-experimental pre-post study

Safety of infliximab and adalimumab in pediatric inflammatory bowel diseases: a real-world analysis from FAERS database

Can Pharmacovigilance Data Represent a Potential Tool for Early Detection of the Antibiotic Resistance Phenomenon?

Practices and awareness of pharmacovigilance in ALERT hospital, Addis Ababa, Ethiopia, a pilot study

General selection criteria for safety and patient benefit [XⅢ]: Comparing the formulation characteristics of brand-name and generic bifonazole creams

Comparative safety of different antibiotic regimens for the treatment of outpatient community-acquired pneumonia among otherwise healthy adults

Evaluating the impact of loperamide on irinotecan-induced adverse events: a disproportionality analysis of data from the World Health Organization pharmacovigilance database (VigiBase)

A real-world pharmacovigilance study of FDA Adverse Event Reporting System (FAERS) for gemcitabine

ASSESMENT OF ATTITUDE AND PRACTICE TOWARDS ADVERSE DRUG REACTION REPORTING OF HEALTH PROFESSIONALS IN REPUBLIC OF NORTH MACEDONIA

Educate to Reduce Unnecessary Antibiotic Prescriptions

Using digital health technologies to optimise antimicrobial use globally

How Will Trump’s Government Impact Health Policy Abroad?

El PRAN celebra 10 años de retos y logros en su jornada anual por el Día Europeo para el Uso Prudente de los Antibióticos

Machine learning algorithms for prediction of measles one vaccination dropout among 12–23 months children in Ethiopia

Reassuring Data on GLP-1 RAs and Pancreatic Cancer Risk

FDA Updates GLP-1 Label With Pulmonary Aspiration Warning

First Trimester Tetracycline Exposure and Risk of Major Congenital Malformations

Collaborative Real-World Evidence Among Regulators: Lessons and Perspectives

Cardiovascular adverse events associated with triptans for treatment of migraine: a pharmacovigilance study of the FDA adverse event reporting system (FAERS)

DNA-Based Chemical Unclonable Functions for Cryptographic Anticounterfeit Tagging of Pharmaceuticals

Pharmacovigilance: the evolution of drug safety monitoring

Adverse drug reactions following treatment of latent tuberculosis infection: a linked national tuberculosis surveillance with claims database

Nirsevimab Resistance Mutations Rare in RSV, Study Shows

Does Antibiotic Use During Influenza Infection Worsen Lung Immunity?

Papel del Servicio de Seguimiento Farmacoterapéutico (SFT) de la farmacia comunitaria en la detección y resolución de reacciones adversas a estatinas vinculadas a posibles errores diagnósticos en pacientes mayores

Global burden of vaccine-associated Guillain-Barré syndrome over 170 countries from 1967 to 2023

Trends of drug shortages in China from 2018 to 2020: A retrospective observational study

Evaluation of β-Blocker-Induced Bradyarrhythmia Using an Analysis of the Japanese Adverse Drug Event Report Database

Cardiovascular adverse events associated with norepinephrine–dopamine reuptake inhibitors: a pharmacovigilance study of the FDA Adverse Event Reporting System

Causal Deep Learning for the Detection of Adverse Drug Reactions: Drug-Induced Acute Kidney Injury as a Case Study

Gabapentinoids and Risk of Hip Fracture

Argus Database Software: Revolutionizing Drug Safety and Pharmacovigilance

Digitalisation of Monitoring Side Effects Before, During and After COVID-19 Vaccines–Analysis of the Impact of the Pandemic on Reporting Side Effects in Republic of Croatia

Meta Analysis of Efficacy and Safety of Traditional Chinese Medicine Combined with Immunosuppressive Agents in the Treatment of IgA Nephropathy

Mutagenicity and genotoxicity evaluation of 15 nitrosamine drug substance-related impurities in human TK6 cells

Sex Differences of Fall-Risk-Increasing Drugs in the Middle-Aged and Elderly: A Pharmacovigilance Analysis of FDA Adverse Event Reporting System

Statistics and Studies on the Impact of Ineffective Medications in Patients

Communities That HEAL Intervention and Mortality Including Polysubstance Overdose Deaths: A Randomized Clinical Trial

Strategies to Help Patients Navigate High Prescription Drug Costs

The Impact of Cyberethics on Healthcare and Public Health Sector

A Clustering Ensemble Method for Drug Safety Signal Detection in Post-Marketing Surveillance

Securing Drug Traceability: Block chain-Enhanced Privacy Protection and Anti-Counterfeit Measures in Pharmaceutical Supply Chains

Availability of Medications for Opioid Use Disorder in US Psychiatric Hospitals

Las XIII Jornadas Nacionales de Farmacovigilancia celebradas por la AEMPS reúnen a más de 500 profesionales sanitarios

Use of real-world data sources to evaluate cancer treatments: current practice and future perspectives

A Prospective Study of the Medication Regimen Complexity Index and Hospitalization Due to Adverse Drug Reactions Among People Living with HIV

Global Differences and Risk Factors Influencing Drug Hypersensitivity Quality of Life: A Multi-Centre, Multi-ethnic Study of Drug Allergy Across Three Continents

Prevalence and factors associated with preventable drug-related emergency department visits (DREDp) in elderly patients

Seguridad de enantato de noretisterona y valerato de estradiol como método anticonceptivo en Perú

Adverse events of topical ocular prostaglandin medications for glaucoma treatment: a pharmacovigilance study based on the FAERS database

Combating Misinformation on Social Media Using Social Noise and Social Entropy as a Measure of Uncertainty

SURVEY OF KNOWLEDGE OF PHARMACOVIGILANCE AND ADVERSE DRUG REACTIONS REPORTING AMONG HEALTHCARE PROVIDERS IN ABUJA, NIGERIA

Drug-induced hyponatraemia and possible related signals: Analysis of 659 cases reported to the Spanish Pharmacovigilance System and disproportionality analysis

A study on user willingness to participate in an adverse drug event information sharing system

A real-world pharmacovigilance study of Ocrelizumab based on FAERS database

Adverse events associated with Tezepelumab: a safety analysis of clinical trials and a pharmacovigilance system

Quantification of the prevalence of harms in healthcare related to drug treatment: reflections regarding the use of definitions developed for other settings to estimate the magnitude of the problem

Exploration of the potential association between newer antiseizure medications and arrhythmias: Integrating pharmacovigilance and bioinformatics evidence

Retrospective Evaluation of the Prevalence and Drug Susceptibility of Candida Species and an Analysis of Risk Factors for Oral Candidiasis

Impact of educational intervention on sensitisation and ADR reporting among paramedics in a teaching hospital in north India

Diabetic adverse events associated with three commonly used statins: a disproportionality analysis based on the FDA adverse event reporting system database

Insights into Fracture Risk with Tenofovir and Entecavir: Evidence from Pharmacovigilance Data

FDA Perspective on the Regulation of Artificial Intelligence in Health Care and Biomedicine

Methylphenidate and Atomoxetine in Pregnancy and Possible Adverse Fetal Outcomes. A Systematic Review and Meta-Analysis

Doctors Caution Over Weight Loss Drug Link to Nurse's Death

UN Meeting Highlights Antimicrobial Resistance “Epiphany”—Lack of Antibiotic Access Is a Key Driver

Boletín sobre Seguridad de Medicamentos de Uso Humano. Septiembre de 2024

Safety of Simultaneous vs Sequential mRNA COVID-19 and Inactivated Influenza Vaccines. A Randomized Clinical Trial

La AEMPS recuerda las condiciones necesarias para la donación de medicamentos en las zonas afectadas por la DANA

Pharmacy Closures and Anticonvulsant Medication Prescription Fills

GLP-1 RAs Safe in the Perioperative Period: New Guidance

Neonatal Colonization With Antibiotic-Resistant Pathogens in Low- and Middle-Income Countries. A Systematic Review and Meta-Analysis

Explainable artificial intelligence (XAI) to find optimal in-silico biomarkers for cardiac drug toxicity evaluation

Online Marketing of Falsified Drugs in Ghana: Content Analysis of Selected Drugs on Social Media

DrugDAGT: a dual-attention graph transformer with contrastive learning improves drug-drug interaction prediction

Exploring the Artificial Intelligence and Its Impact in Pharmaceutical Sciences: Insights Toward the Horizons Where Technology Meets Tradition

Prescribing Pattern and Safety Profile of Biological Agents for Psoriasis in Real-World Practice: A Four-Year Calabrian Pharmacovigilance Analysis

Diagnosing and Treating ADHD in Adults. Balancing Individual Benefits and Population Risks

High-Risk Medications in Persons Living With Dementia. A Randomized Clinical Trial

Analysis on Innovation and Application of Anti-counterfeiting Technology of Printed Matter

Trends in Antidiabetic Drug Use and Safety of Metformin in Diabetic Patients with Varying Degrees of Chronic Kidney Disease from 2010 to 2021 in Korea: Retrospective Cohort Study Using the Common Data Model

Artificial Intelligence (AI) Applications in Drug Discovery and Drug Delivery: Revolutionizing Personalized Medicine

Knowledge attitude and practice of pharmacovigilance among community pharmacy in India: a questionnaire study

Curcuma-Based Nutritional Supplements and Risk of Age-Related Macular Degeneration

Drug-induced myocarditis: a real-world pharmacovigilance study using the FDA adverse event reporting system database

Acute toxicity and anti-inflammatory activity of an improved traditional medicine developed in Burkina Faso

Risk of Inflammatory Central Nervous System Diseases After Tumor Necrosis Factor–Inhibitor Treatment for Autoimmune Diseases. A Systematic Review and Meta-Analysis

Upadacitinib in Adolescents With Moderate to Severe Atopic Dermatitis. Analysis of 3 Phase 3 Randomized Clinical Trials Through 76 Weeks

Safety study on adverse events of zanubrutinib based on WHO-VigiAccess and FAERS databases

Analysis of rational prescription of medicines by village clinics: a repeated cross-sectional study of a province in eastern China

Inhaled Reliever Therapies for Asthma. A Systematic Review and Meta-Analysis

La AEMPS lanza la campaña #EsPopularPeroNoCiencia frente a las seudoterapias

FDA Okays Abuse-Deterrent Opioid for Severe Pain

Michigan Oncologist Charged in Scheme to Illegally Sell Cancer Drugs

Outpatient Antibiotic Use and Treatment Failure Among Children With Pneumonia

Cardiovascular Risks With SGLT2 Inhibitors in Clinical Practice Among Patients With Type 2 Diabetes

The African Medicines Agency and Medicines Regulation: Progress, challenges, and recommendations

Substance Use Disorders Crisis Intervention Training (CIT)

Prevalence of treatment-related adverse events (TRAEs) with antibody-drug conjugates in metastatic breast cancer patients: A systematic review and meta-analysis

Establishing a multi‐method approach for unprecedented detection and quantification of 13 genotoxic impurities (GTIs) in Apixaban drug substance through ultra-performance liquid chromatography (UPLC)